[Buflomedil in arterial occlusive disease. Results of a controlled study].
D000368:Aged; D001157:Arterial Occlusive Diseases / Q000175:diagnosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005263:Femoral Artery / Q000473:pathology; D006801:Humans; D007083:Iliac Artery / Q000473:pathology; D007383:Intermittent Claudication / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D010919:Placebos; D011759:Pyrrolidines / Q000627:therapeutic use*; D014463:Ultrasonography; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010919:Placebos; D011759:Pyrrolidines; D014665:Vasodilator Agents; C010651:buflomedil
Buflomedil bei arterieller Verschlusskrankheit.